Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|8|3|159-172

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.8, Iss.3, 2008-09, pp. : 159-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Cannabinoids in CNS Disease

By Croxford J.L.  

CNS Drugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 179-202

Adis International

Access to resources Recommend Favorite

Pro-Drugs for Indirect Cannabinoids as Therapeutic Agents

By  

Current Drug Delivery, Vol. 5, Iss. 4, 2008-10 ,pp. : 243-247

Bentham Science Publishers

Access to resources Recommend Favorite

The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimer's Disease: Therapeutic Implications

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 3, 2005-06 ,pp. : 223-233

Bentham Science Publishers

Access to resources Recommend Favorite

The Chemokine CXCL10 as a Therapeutic Target in Animal Models of Neuroinflammatory Disease

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 10, 2006-12 ,pp. : 683-688

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Agents for Alzheimer's Disease

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 4, 2005-01 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite